Literature DB >> 16861976

Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis-a UK-wide study.

Peter N Furness1, Nick Taub.   

Abstract

We sought to assess the interobserver variation of the new International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification of lupus nephritis when compared with the previous World Health Organization classification, when used by pathologists throughout the UK. We also sought differences in how the 2 classifications were applied to a single set of biopsies. Twenty unselected renal biopsies showing lupus nephritis were circulated to pathologists in the UK National Renal Pathology External Quality Assessment Scheme, before the ISN/RPS scheme was published, with a request to apply the World Health Organization classification. The same slides were recirculated approximately 1 year later with a request to apply the ISN/RPS classification. A significant improvement in interobserver reproducibility was demonstrated by the new classification (kappa 0.53 vs. 0.44, P = 0.002). The reproducibility of the assessment of disease activity and chronicity remains suboptimal (kappa = 0.33). The new classification tends to produce more diagnoses of Class IV lupus nephritis, with fewer diagnoses of Classes III and V. The improvement in interobserver reproducibility indicates that an important aim of the new classification has been achieved. Further work is needed to determine whether the increase in diagnosis of Class IV nephritis represents an improvement in biopsy interpretation or a divergence from the previous classification, as the latter could undermine attempts to relate results from the new system to treatment strategies based on clinical trials which used the old.

Entities:  

Mesh:

Year:  2006        PMID: 16861976     DOI: 10.1097/00000478-200608000-00015

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  26 in total

1.  Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes.

Authors:  Catharina M Haring; Anke Rietveld; Jan A J G van den Brand; Jo H M Berden
Journal:  J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 10.121

Review 2.  The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic Lesions.

Authors:  Suzanne Wilhelmus; Charles E Alpers; H Terence Cook; Franco Ferrario; Agnes B Fogo; Mark Haas; Kensuke Joh; Laure-Hélène Noël; Surya V Seshan; Jan A Bruijn; Ingeborg M Bajema
Journal:  J Am Soc Nephrol       Date:  2015-07-07       Impact factor: 10.121

3.  A study of interobserver reproducibility of morphologic lesions of focal segmental glomerulosclerosis.

Authors:  Shane M Meehan; Anthony Chang; Ian W Gibson; Lisa Kim; Neeraja Kambham; Zoltan Laszik
Journal:  Virchows Arch       Date:  2012-12-21       Impact factor: 4.064

Review 4.  Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Authors:  Feng Yu; Mark Haas; Richard Glassock; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

5.  Artificial Intelligence: The Next Frontier in Kidney Biopsy Evaluation.

Authors:  Jean Hou; Cynthia C Nast
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-16       Impact factor: 8.237

6.  ISN/RPS 2003 class II mesangial proliferative lupus nephritis: a comparison between cases that progressed to class III or IV and cases that did not.

Authors:  Seung Geun Lee; Yong Mee Cho; Min Wook So; Sung Soo Kim; Yong-Gil Kim; Chang-Keun Lee; Bin Yoo
Journal:  Rheumatol Int       Date:  2011-07-16       Impact factor: 2.631

Review 7.  Treatment of proliferative lupus nephritis: a slowly changing landscape.

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Nat Rev Nephrol       Date:  2010-12-21       Impact factor: 28.314

8.  Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis.

Authors:  Emilie C Rijnink; Y K Onno Teng; Suzanne Wilhelmus; Mathilde Almekinders; Ron Wolterbeek; Karlien Cransberg; Jan A Bruijn; Ingeborg M Bajema
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-04       Impact factor: 8.237

9.  Mycophenolate mofetil in the treatment of lupus nephritis.

Authors:  Patrick Fk Yong; David P D'Cruz
Journal:  Biologics       Date:  2008-06

Review 10.  Usefulness of ISN/RPS classification of lupus nephritis.

Authors:  Ken-Ei Sada; Hirofumi Makino
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.